Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001090613 | SCV001246239 | pathogenic | not provided | 2017-08-01 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV002290591 | SCV002581083 | pathogenic | Usher syndrome type 2A | 2022-07-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001090613 | SCV003524042 | pathogenic | not provided | 2021-12-24 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 870919). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 24944099). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val4745Argfs*4) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |
Genome- |
RCV002290591 | SCV004183088 | pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing |